Table 2.
Drug therapy in group “M” and group “T”.
| Group of Drugs | Group “M” (n = 113) | Group “T” (n = 60) |
p 1–4 |
p 2–5 |
p 3–6 |
||||
|---|---|---|---|---|---|---|---|---|---|
| 7th–9th Day | 12th Week | 48th Week | 7th–9th Day | 12th Week | 48th Week | ||||
| 1 | 2 | 3 | 4 | 5 | 6 | ||||
| Beta-blockers | 86 (76%) | 81 (73%) | 74 (65%) | 48 (80%) | 40 (67%) | 36 (60%) | 0.56 | 0.494 | 0.476 |
| ACE inhibitors/ARBs | 93 (82%) | 87 (77%) | 61 (70%) | 53 (88%) | 44 (73%) | 39 (65%) | 0.299 | 0.594 | 0.163 |
| Diuretics | 21 (19%) | 17 (15%) | 15 (13%) | 9 (15%) | 7 (12%) | 7 (12%) | 0.554 | 0.541 | 0.763 |
| Calcium channel blockers | 10 (8.8%) | 13 (12%) | 8 (7.1%) | 4 (6.7%) | 5 (8.3%) | 4 (6.7%) | 0.617 | 0.516 | 0.919 |
| Class III antiarrhythmic agents | 6 (5.3%) | 2 (1.8%) | 3 (2.7%) | 3 (5%) | 1 (1.7%) | 1 (1.7%) | 0.931 | 0.961 | 0.681 |
Note: ARBs—angiotensin II receptor blockers, ACE inhibitors—angiotensin-converting enzyme inhibitors.